Jennifer Brigitte Green, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Duke Box 3850, Durham, NC 27715
Phone (919) 668-8725
Email address green094@mc.duke.edu

Diabetes Mellitus: Prevention strategies, predictors, treatment effects, and cardiovascular outcomes
Thyroid Disease
Bone and Calcium Disorders

Education and Training

  • Resident, Internal Medicine, University of North Carolina at Chapel Hill School of Medicine, 1994 - 1996
  • Intern, Internal Medicine, University of North Carolina at Chapel Hill School of Medicine, 1993 - 1994
  • M.D., University of Virginia, 1993

Publications

Reed, SD, Li, Y, Leal, J, Radican, L, Adler, AI, Alfredsson, J, Buse, JB, Green, JB, Kaufman, KD, Riefflin, A, Van de Werf, F, Peterson, ED, Gray, AM, Holman, RR, and TECOS Study Group, . "Longitudinal Medical Resources and Costs Among Type 2 Diabetes Patients Participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." Diabetes, obesity & metabolism (March 23, 2018).

PMID
29573215
Full Text

Standl, E, Stevens, SR, Armstrong, PW, Buse, JB, Chan, JCN, Green, JB, Lachin, JM, Scheen, A, Travert, F, Van de Werf, F, Peterson, ED, Holman, RR, and TECOS Study Group, . "Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype." Diabetes care 41, no. 3 (March 2018): 596-603.

PMID
29311155
Full Text

Cefalu, WT, Kaul, S, Gerstein, HC, Holman, RR, Zinman, B, Skyler, JS, Green, JB, Buse, JB, Inzucchi, SE, Leiter, LA, Raz, I, Rosenstock, J, and Riddle, MC. "Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum." Diabetes care 41, no. 1 (January 2018): 14-31.

PMID
29263194
Full Text

Sharma, A, Green, JB, Dunning, A, Lokhnygina, Y, Al-Khatib, SM, Lopes, RD, Buse, JB, Lachin, JM, Van de Werf, F, Armstrong, PW, Kaufman, KD, Standl, E, Chan, JCN, Distiller, LA, Scott, R, Peterson, ED, Holman, RR, and TECOS Study Group, . "Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial." Diabetes care 40, no. 12 (December 2017): 1763-1770.

PMID
28986504
Full Text

Butler, J, Hamo, CE, Filippatos, G, Pocock, SJ, Bernstein, RA, Brueckmann, M, Cheung, AK, George, JT, Green, JB, Januzzi, JL, Kaul, S, Lam, CSP, Lip, GYH, Marx, N, McCullough, PA, Mehta, CR, Ponikowski, P, Rosenstock, J, Sattar, N, Salsali, A, Scirica, BM, Shah, SJ, Tsutsui, H, Verma, S, Wanner, C, Woerle, H-J, Zannad, F, Anker, SD, and EMPEROR Trials Program, . "The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors." European journal of heart failure 19, no. 11 (November 2017): 1390-1400. (Review)

PMID
28836359
Full Text

Navar, AM, Gallup, DS, Lokhnygina, Y, Green, JB, McGuire, DK, Armstrong, PW, Buse, JB, Engel, SS, Lachin, JM, Standl, E, Van de Werf, F, Holman, RR, Peterson, ED, and TECOS Study Group, . "Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin." Hypertension (Dallas, Tex. : 1979) 70, no. 5 (November 2017): 907-914.

PMID
28847886
Full Text

Engel, SS, Bethel, MA, Garg, J, Stevens, SR, Lokhnygina, Y, Josse, RG, Green, JB, Peterson, ED, Holman, RR, and Grp, TECOSS. "Time to insulin in the Trial Evaluating Cardiovascular Outomes with Sitagliptin (TECOS)." September 2017.

Scholars@Duke

Paul, S, Green, JB, Atherton, J, and Montvida, O. "Risk of pancreatic diseases by second-line anti diabetes drug class: real world based evidence." September 2017.

Scholars@Duke

Pagidipati, NJ, Navar, AM, Pieper, KS, Green, JB, Bethel, MA, Armstrong, PW, Josse, RG, McGuire, DK, Lokhnygina, Y, Cornel, JH, Halvorsen, S, Strandberg, TE, Delibasi, T, Holman, RR, Peterson, ED, and TECOS Study Group, . "Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)." Circulation 136, no. 13 (September 2017): 1193-1203.

PMID
28626088
Full Text

Herbst, R, Bolton, W, Shariff, A, and Green, JB. "Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions." Current diabetes reports 17, no. 9 (September 2017): 67-. (Review)

PMID
28726152
Full Text

Pages